Photobiomodulation for the Treatment of Retinal Injury and Retinal Degenerative Diseases
Retinal injury and retinal degenerative diseases are a leading causes of visual impairment in the developed world. Mitochondrial dysfunction and oxidative stress play key roles in the pathogenesis of retinal injury and disease. The development and testing of strategies designed to improve mitochondrial function and attenuate oxidative stress are essential for combating retinal disease. One strategy involves the use of photobiomodulation. Photobiomodulation, low-energy photon irradiation by light in the far-red to near-infrared (NIR) range using low energy lasers or light-emitting diode (LED) arrays, has been applied clinically in the treatment soft tissue injuries and acceleration of wound healing for more than 30 years. The therapeutic effects of photobiomodulation have been hypothesized to be mediated by intracellular signaling mechanisms triggered by the interaction of farred to NIR photons with the mitochondrial photoacceptor molecule cytochrome oxidase which culminate in improved mitochondrial energy metabolism, increased synthesis of cytoprotective factors and cell survival.
The therapeutic potential of 670 nm LED photobiomodulation administered once per day at a fluence of 4 J/cm2 was investigated in established experimental models of retinal injury, retinal toxicity and retinal disease. Photobiomodulation stimulated retinal wound healing following high-intensity laser-induced retinal injury. Photobiomodulation not only enhanced the rate of wound healing, it also prevented the loss of retinal and cortical visual function induced by laser-induced retinal injury. In a rodent model of retinal mitochondrial toxicity, photobiomodulation preserved retinal function and prevented photoreceptor damage. Moreover, molecular studies revealed that photobiomodulation induced significant upregulation of gene expression pathways involved in mitochondrial energy production and cytoprotection in the retina. Retinitis pigmentosa is the leading cause of vision loss due to retinal degeneration. Photobiomodulation administered during the critical period of photoreceptor development in a rat model of retinitis pigmentosa increased retinal mitochondrial cytochrome oxidase activity, upregulated the production of retinal antioxidants, increased the production of retinal neurotrophic factors and prevented photoreceptor cell death.
The molecular, biochemical and functional insights obtained from this research provide crucial information needed for a comprehensive FDA approval for the use of photobiomodulation in the treatment of retinal diseases. From a basic science perspective, they substantiate previous in vitro investigations and support the hypothesis that photobiomodulation augments mitochondrial function and stimulates cytoprotective pathways to prevent retinal damage. From a clinical perspective, they document the therapeutic potential of 670 nm photon therapy in experimental models of retinal injury, retinal toxicity and retinitis pigmentosa, thus setting the stage for clinical trials of photobiomodulation in human disease.
KeywordsPhotobiomodulation mitochondrial dysfunction oxidative stress retinal injury retinal degenerative disease.
- 2.Kanwar, M. et al., Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase.Google Scholar
- 3.Ranchon, I. et al., Free radical spin trap SPBN protects against light damage but does not rescue P23H and S334ter rhodopsin transgenic rats from inherited retinal degeneration. J Neurosci, 2003 23: 6050–6057.Google Scholar
- 7.Eells, J. et al., Therapeutic photobiomodulation for methanol-induced retinal toxicity. PNAS, 2003 100(6).Google Scholar
- 14.Eells, J. et al., Near-infrared light therapy for retinitis pigmentosa. Invest Ophthalmol Vis Sci, 2006: 47. ARVO Abstract 1022.Google Scholar
- 15.Geller, S. et al., Toxicity of hyperoxia to the retina: evidence from the mouse, in Retinal Degenerative Disease, J. Hollyfield, G. Anderson, and M. LaVail, Editors. 2005, Springer: Berlin/Heidelberg. pp. 425–438.Google Scholar
- 19.Yu, D. et al., Photoreceptor death, trophic factor expression, retinal oxygen status, and photoreceptor function in the P23H rat. Invest Ophthalmol Vis Sci, 2004 45(6).Google Scholar
- 20.Valter, K. et al., Photoreceptor dystrophy in the RCS rat: roles of oxygen, debris and bFGF. Invest Ophthal Vis Sci, 1998 39: 2427–2442.Google Scholar
- 23.Bravo-Nuevo, A. et al., Mitochondrial deletions in normal and degenerating rat retina, in Retinal Degenerations: Mechanisms and Experimental Therapy, M. La Vail, J. Hollyfield, and G. Anderson, Editors. 2003, Kluwer/Plenum: New York. pp. 241–248.Google Scholar
- 24.Qi, X. et al., Mitochondrial protein nitration primes neurodegeneration in experimental autoimmune encephalomyelitis. J Biol Chem, 2006.Google Scholar
- 26.Maslim, J. et al., Tissue oxygen during a critical developmental period controls the death and survival of photoreceptors. Invest Ophthal Vis Sci, 1997 38: 1667–1677.Google Scholar
- 27.Machida, S. et al., P23H rhodopsin transgenic rat: correlation of retinal function with histopathology. Invest Ophthalmol Vis Sci, 2000 41(10): 3200–3209.Google Scholar
- 30.Schuschereba ST, Cross MT, Pizarro JM, et al., Pretreatment with hydroxyethyl starch-deferoxamine but not methylprednisolone reduces secondary injury to retina after laser irradiation. Lasers Light, 1997 8: 1–14.Google Scholar
- 31.Whelan, HT, Wong-Riley, MTT, Eells, JT, VerHoeve, JN, Das, R, Jett, M., DARPA soldier self care: rapid healing of laser eye injuries with light-emitting diode technology. NATO RTO-MP-HFM, 2005 109: 1–18.Google Scholar